Los Angeles Capital Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.4M | Sell |
10,200
-35,486
| -78% | -$16.4M | 0.02% | 413 |
|
|
2026
Q1 | $21.9M | Sell |
45,686
-44,055
| -49% | -$22.6M | 0.09% | 181 |
|
|
2025
Q4 | $52.1M | Buy |
89,741
+9,380
| +12% | +$5.32M | 0.18% | 99 |
|
|
2025
Q3 | $41.3M | Buy |
80,361
+75,696
| +1,623% | +$33M | 0.14% | 118 |
|
|
2025
Q2 | $1.46M | Sell |
4,665
-22,843
| -83% | -$6.86M | 0.01% | 534 |
|
|
2025
Q1 | $8.38M | Sell |
27,508
-65,852
| -71% | -$22.2M | 0.04% | 232 |
|
|
2024
Q4 | $31M | Sell |
93,360
-70,967
| -43% | -$24.1M | 0.13% | 144 |
|
|
2024
Q3 | $54.9M | Sell |
164,327
-40,707
| -20% | -$15.5M | 0.22% | 96 |
|
|
2024
Q2 | $84.4M | Sell |
205,034
-55,411
| -21% | -$21.9M | 0.3% | 69 |
|
|
2024
Q1 | $105M | Buy |
260,445
+6,320
| +2% | +$2.22M | 0.36% | 61 |
|
|
2023
Q4 | $77.9M | Buy |
254,125
+82,068
| +48% | +$22.2M | 0.29% | 78 |
|
|
2023
Q3 | $41.7M | Sell |
172,057
-16,767
| -9% | -$4.29M | 0.18% | 112 |
|
|
2023
Q2 | $45.3M | Buy |
188,824
+165,032
| +694% | +$34.3M | 0.18% | 116 |
|
|
2023
Q1 | $4.47M | Sell |
23,792
-247
| -1% | -$51.1K | 0.02% | 364 |
|
|
2022
Q4 | $5.11M | Buy |
24,039
+6,125
| +34% | +$1.22M | 0.02% | 375 |
|
|
2022
Q3 | $2.82M | Sell |
17,914
-800
| -4% | -$128K | 0.01% | 446 |
|
|
2022
Q2 | $2.8M | Buy |
18,714
+6,203
| +50% | +$898K | 0.01% | 456 |
|
|
2022
Q1 | $2.05M | Buy |
12,511
+89
| +0.7% | +$14.7K | 0.01% | 527 |
|
|
2021
Q4 | $2.7M | Buy |
+12,422
| New | +$2.6M | 0.01% | 450 |
|
|
2021
Q2 | – | Sell |
-3,468
| Closed | -$569K | – | 1620 |
|
|
2021
Q1 | $569K | Sell |
3,468
-9,678
| -74% | -$1.48M | ﹤0.01% | 1164 |
|
|
2020
Q4 | $1.83M | Sell |
13,146
-12,814
| -49% | -$1.62M | 0.01% | 687 |
|
|
2020
Q3 | $2.9M | Sell |
25,960
-17,600
| -40% | -$2.04M | 0.01% | 473 |
|
|
2020
Q2 | $4.05M | Sell |
43,560
-3,025
| -6% | -$257K | 0.02% | 439 |
|
|
2020
Q1 | $3.42M | Sell |
46,585
-31,340
| -40% | -$2.72M | 0.02% | 410 |
|
|
2019
Q4 | $6.55M | Sell |
77,925
-4,650
| -6% | -$360K | 0.03% | 357 |
|
|
2019
Q3 | $6.94M | Buy |
82,575
+28,770
| +53% | +$2.17M | 0.04% | 347 |
|
|
2019
Q2 | $3.52M | Buy |
53,805
+43,696
| +432% | +$2.52M | 0.02% | 520 |
|
|
2019
Q1 | $596K | Sell |
10,109
-44,816
| -82% | -$2.68M | ﹤0.01% | 1031 |
|
|
2018
Q4 | $2.91M | Buy |
54,925
+835
| +2% | +$45.8K | 0.02% | 469 |
|
|
2018
Q3 | $3.24M | Buy |
+54,090
| New | +$2.96M | 0.02% | 544 |
|
Other funds holding MEDP
WA
Los Angeles Capital Management's MEDP Position: Q2 2026 in Review
Los Angeles Capital Management reduced its Medpace (MEDP) stake by 78% in Q2 2026, selling an estimated $16.4M and leaving 10,200 shares worth $5.4M. The position accounts for 0.02% of the portfolio, ranked #413.
Los Angeles Capital Management first reported a position in MEDP in Q3 2018 and has held it in 30 quarters since. The position peaked at $105M in Q1 2024. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Los Angeles Capital Management held 10,200 shares of Medpace worth $5.4M as of Q2 2026.
- Los Angeles Capital Management sold 35,486 Medpace shares in Q2 2026, an estimated $16.4M.
- Medpace made up 0.02% of Los Angeles Capital Management's portfolio in Q2 2026, its #413 holding.
- Los Angeles Capital Management first reported a position in Medpace in Q3 2018 and has held it in 30 quarters since.
- Los Angeles Capital Management's Medpace position peaked at $105M in Q1 2024.
- 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.